杜凯丽,旦增诺扬,杨发满

慢性阻塞性肺疾病（Chronic Obstructive Pulmonary Disease，COPD）是一种高发病率、高死亡率的疾病，疾病负担重。肌少症是其重要合并症，近来多项研究表明，肌少症与慢阻肺高度相关。本文对近年来肌少症和慢阻肺的有关研究进展作出总结，旨在增强对慢阻肺相关肌少症情况的了解，进而早期识别慢阻肺患者合并肌少症的危险因素，对其控制和干预提供支持。

慢性阻塞性肺疾病；肌肉减少症；危险因素

[1] Wang C, Xu J, Yang L,et al. China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018 Apr 28;391(10131):1706-1717. [2] Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 REPORT)[EB/OL]. [2020‐11‐18]. [3] Barnes P J. COPD 2020: new directions needed[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2020, 319(5): L884-L886. [4] Chen LK, Woo J, Assantachai P, Auyeung TW,et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. [5] Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):290-8. [6] Ma K, Huang F, Qiao R, et al. Pathogenesis of sarcopenia in chronic obstructive pulmonary disease[J]. Frontiers in physiology, 2022, 13: 850964. [7] Dhillon, Robinder J.S.; Hasni, Sarfaraz (2017). Pathogenesis and Management of Sarcopenia. Clinics in Geriatric Medicine, 33(1), 17–26. [8] 赵娜,王静,海荣,乔彩霞,马晓敏,唐月影&屈红蕾.(2019).老年慢性阻塞性肺病与肌肉减少症的相关性研究进展.内蒙古医科大学学报(05),558-560. [9] Nan Y, Zhou Y, Dai Z, Yan T, Zhong P, Zhang F, Chen Q, Peng L. Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia. Front Nutr. 2023 Aug 8;10:1214684. [10] 卢新卫,李海天,王晶,等.衡水地区慢阻肺患者营养不良的影响因素[J].现代预防医学,2024,51(01):45-49. [11] Pan L, Xie W, Fu X, Lu W, Jin H, Lai J, Zhang A, Yu Y, Li Y, Xiao W. Inflammation and sarcopenia: A focus on circulating inflammatory cytokines. Exp Gerontol. 2021 Oct 15;154:111544. [12] 杨君红,梁兰玉,单清.慢性阻塞性肺疾病合并肌少症研究进展[J].实用临床医药杂志,2021,25(03):120-124. [13] Lage VKDS, de Paula FA, Lima LP, Santos JNV, Dos Santos JM, Viegas ÂA, da Silva GP, de Almeida HC, Rodrigues ALDSNT, Leopoldino AAO, de Avelar NCP, Danielewicz AL, Parentoni AN, Teixeira AL, Oliveira MX, Lacerda ACR, Mendonça VA. Plasma levels of myokines and inflammatory markers are related with functional and respiratory performance in older adults with COPD and sarcopenia. Exp Gerontol. 2022 Jul;164:111834. [14] Jaitovich A, Barreiro E. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients. Am J Respir Crit Care Med. 2018 Jul 15;198(2):175-186. [15] Ito A, Hashimoto M, Tanihata J, et al. Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia[J]. Journal of cachexia, sarcopenia and muscle, 2022, 13(3): 1864-1882. [16] 南亚昀,彭琳琳,高叙凡,等.慢性阻塞性肺疾病合并肌少症[J].中国实用内科杂志,2022,42(8):626. [17] 张雅迪,杨万春.呼吸肌功能的锻炼对慢性阻塞性肺疾病患者肺部功能的干预效果[J].智慧健康,2021,7(33):39-41.

点击下载PDF